THE EXISTENCE OF AN INTERACTION between coronary perfusion and cardiac contractility is well established (22) . An increase in coronary perfusion with a concomitant increased filling of the coronary vessels leads to an increase in cardiac contractility and cardiac oxygen consumption known as the Gregg effect (1, 3, 14, 18, 22, 36) . Filling of the coronary vessels will change hoop (circumferential) stress in the vessel wall, thereby mechanically deforming the membranes of myocardial cells. Mechanical deformation of cardiomyocytes activates stretch-activated ion channels (SACs) (24, 27, 28, 37, 39, 40) , thereby conducting Ca 2ϩ , Na ϩ , or K ϩ cations (7, 8, 35, 37, 39, 40) , which may affect the contractile state of the myocardium. Besides hoop stress, a change in perfusion will change also shear stress and may thereby induce endothelium-dependent nitric oxide (NO) release. Because NO has been shown to have positive inotropic effects at low concentration and negative inotropic effects at high concentration (26, 30) , there could be an effect of perfusion-induced NO release on the contractility of cardiomyocytes.
Therefore, we investigated the role of SACs and NO on the coronary perfusion-induced increase in cardiac contractility. In isolated perfused papillary muscles of the rat, coronary perfusion pressure was increased via a brief "perfusion pulse," repetitive perfusion pulses, or a sustained perfusion increase "perfusion step." The effects of the perfusion increase on isometric force development were tested before and after addition of the SAC blockers gadolinium (III) chloride hexahydrate (Gd 3ϩ ) and streptomycin, the NO synthase (NOS) inhibitor N -nitro-L-arginine (L-NNA), the NO donor sodium nitroprusside (SNP), and the L-type Ca 2ϩ channel blocker verapamil. Our results indicate that a brief, repetitive, or sustained increase in coronary perfusion augments cardiac contractility through activation of stretch-activated ion channels, whereas endothelial NO release and L-type Ca 2ϩ channels are not involved.
METHODS
Preparation and setup. All animals were treated according to guidelines of the Animal Experimental Committee of the Vrije Universiteit of Amsterdam, The Netherlands. Under ether anesthesia, the hearts of 50 male Wistar rats (300-400 g body wt) were quickly removed and perfused via the aorta with a crystalloid solution (for composition, see below). To prevent contraction of the heart, external Ca 2ϩ concentration ([Ca 2ϩ ]) was kept at 0.5 and 25 mmol/l, respectively, and 2,3-butanedione monoxime was added. A papillary muscle with part of the septum and septal artery was removed from the right ventricle and transferred to the experimental superfusion bath. The septum was clamped on a Perspex plate and the muscle tendon was attached to a force transducer (model KG4, Scientific Instruments; Heidelberg, Germany) with a piece of silk thread. The septal artery was cannulated using a glass cannula and connected to a pressurized reservoir through a pressure difference meter (model SCX01DN, Sensym) for flow measurements. Muscle diameter was determined with the use of a video analyzing system (36) .
Bath (superfusion) and pressurized reservoir (perfusion) were filled with identical crystalloid solution containing (in mmol/l) 120 NaCl, 4.9 KCl, 1.2 MgSO 4, 1.8 NaH2PO4, 1 CaCl 2, 10 glucose, 5 HEPES, 20 NaHCO3, 15 choline chloride, and 0.01 adenosine, and then gassed with 95% O 2-5% CO 2. Solution was kept at 27°C and pH was set at 7.45.
Muscles were stimulated via a pair of platinum electrodes at 0.2Hz to obtain muscle-isometric contractions. Passive force (F pas; the force imposed on the resting muscle) and developed force (F dev; the difference between the total force produced during contraction and F pas) were measured at 95% L max, with Lmax being the muscle length at which maximal isometric force was developed.
Experimental protocols. After an equilibration period of 60 min in control conditions, different perfusion protocols were tested to investigate adaptation processes and to exclude interference of preload changes. In the first protocol, a brief increase (3-4 s) from low (10 cmH2O) to high (80 cmH2O) coronary perfusion pressure (P-pulse or perfusion pulse) was applied between two isometric contractions. In the second protocol, coronary perfusion pressure was increased from low-to-high perfusion and sustained until force development reached a steady state (perfusion step). In four muscles of the Gd 3ϩ group (see Experimental protocols), we performed an additional perfusion protocol to investigate a different application of the stretch (perfusion pressure). Four muscles were exposed to 10 consecutive perfusion pulses, and each pulse was given between two isometric contractions (repetitive perfusion pulses).
The minimal perfusion pressure of 10 cmH2O was used because at lower perfusion pressures the vasculature would collapse completely, resulting in endothelial damage, and thus affecting contractile state. The maximal perfusion pressure of 80 cmH2O (ϳ65 mmHg) was used because this reflects normal perfusion pressure in the septal artery and it is the perfusion pressure at which the increase in Fdev is maximal.
The perfusion protocols were performed in control conditions and were repeated after 30 min of incubation with one of the pharmacological agents. A first group of papillary muscles (n ϭ 7) was incubated with Gd 3ϩ (10 mol/l), a nonspecific stretch-activated ion channel blocker. A second group of papillary muscles (n ϭ 10) was incubated with the NOS inhibitor L-NNA (100 mol/l), and a third group (n ϭ 6) was incubated with the NO donor SNP (10 mol/l). To support that the Gd 3ϩ -induced effects were related to SACs, a fourth group of muscles (n ϭ 8) was incubated with streptomycin (40 and 100 mol/l), which is also known to block SACs (19) . In this group, only the perfusion step was performed. The role of inhibition of L-type Ca 2ϩ channels by Gd 3ϩ was investigated in a fifth and sixth group of papillary muscles. The fifth group (n ϭ 6) was incubated with the L-type Ca 2ϩ channel blocker verapamil (0.1 mol/l) and again only a perfusion step was performed. The sixth group (n ϭ 6) was loaded with the cell-permeant acetoxymethyl ester form of the fluorescent intracellular Ca 2ϩ -indicator fura 2 (Molecular Probes F1221, final concentration 10 mol/l) and basal force development was measured. The ratio of fura 2 fluorescence at 520 nm after excitation at wavelengths 340 and 380 nm was collected with a photomultiplier (model MPS20/21, Zeiss) before and after addition of 10 mol/l Gd 3ϩ , with acquisition rate of 66 Hz. In all experiments, the fura 2 signal was at least five times above background level (autofluorescence). Finally, in a seventh group of muscles, the effect of Gd 3ϩ (10 mol/l) on the perfusion step response was investigated under HEPES conditions (n ϭ 7).
Data analysis. Force (mN/mm 2 ) was normalized by dividing measured force by muscle cross-sectional area (mm 2 ). The peak 340-to-380-nm ratio for each muscle in control conditions was set to 1.00 and all other Ca 2ϩ transients were normalized with respect to this value (normalized 340-to-380-nm ratio). The fluorescence signal was not converted to intracellular [Ca 2ϩ ] ([Ca 2ϩ ]i) values with an in vivo calibration procedure because accurate reproducible calibration procedures without compartmentalization problems are difficult (38) and our primary interest was in the relative changes of [Ca 2ϩ ]i. Statistical differences within each group of muscles were tested with a one-or two-way repeated-measures analysis of variance, followed by a Bonferroni or Dunnett post hoc test; P Ͻ 0.05 was considered significant. All data are expressed as means Ϯ SE.
RESULTS

Perfusion step and perfusion pulse.
Raw data tracings of the effects induced by a perfusion pulse (A) and perfusion step (B) are presented in Fig. 1 . A perfusion pulse results in an immediate increase in force, which slowly decreases and returns to basal values after ϳ50-60 s. A perfusion step increases force during the first 7-9 contractions; after 40 s, the force slowly starts to decrease, reaching a steady state after ϳ125 s (25 contractions). Figure 2 shows the averaged absolute increase in F dev after a perfusion pulse ( Fig. 2A ) and perfusion step ( group, 2.7 Ϯ 0.9 mN/mm 2 for the L-NNA group and 3.3 Ϯ 0.9 mN/mm 2 for the SNP group. Hereafter, the F dev slowly returns to basal values after ϳ50 s. In the Gd 3ϩ group, F pas is significantly increased in the first contraction after the P-pulse, 0.36 Ϯ 0.07 mN/mm 2 (P Ͻ 0.05), whereas in the second contraction (10 s) after the P-pulse, the F pas value returns to basal values (0.1 Ϯ 0.04 mN/mm 2 , P Ͼ 0.05). Also, the muscle diameter ( Fig. 1 ) is related to vascular filling and emptying (1) and returns to basal values within 10 s. This indicates that a perfusion pulse induces a process that results in a transient increase of F dev . The perfusion-pulse-induced increase in F dev is completely blunted by SAC blockade (maximum increase of F dev : 0.2 Ϯ 0.3 mN/mm 2 ), whereas NOS inhibition or NO donation has no effect (maximum increase of F dev : 3.1 Ϯ 0.6.3 and 3.4 Ϯ 0.9 mN/mm 2 , respectively). In the Gd 3ϩ group, the increase in F pas in the first contraction after the P-pulse (0.30 Ϯ 0.27 mN/mm the F pas value in the second contraction following Ppulse (0.09 Ϯ 0.05 mN/mm 2 , P Ͼ 0.05) are not affected by Gd 3ϩ . Similar results for F pas are found for the L-NNA and SNP group (data not shown).
A perfusion step results in an immediate increase in F dev that is not different from the perfusion-pulseinduced increase in F dev and reaches a maximum increase (⌬F max dev ) after 40 s (Table 1 and Fig. 2) . Hereafter, the F dev starts to decline but remains significantly increased in the steady state (⌬F SSdev ) ( Table  1 and Fig. 2 ). The time constant of the increase in F dev was not different for the three control groups (8.9 Ϯ 6.0 s for Gd 3ϩ group, 10.9 Ϯ 8.3 s for the L-NNA group and 16.2 Ϯ 14.4 for the SNP group).
The perfusion step-induced increase in F dev is completely blunted by SAC blockade with 10 mol/l Gd 3ϩ (⌬F SSdev : 0.8 Ϯ 1.3 mN/mm 2 , Table 1 ) and is dose dependently inhibited by streptomycin, another SAC blocker (2.8 Ϯ 1.0 and 1.3 Ϯ 0.9 mN/mm 2 at 40 and 100 mol/l, respectively, Table 1 ). NOS inhibition, NO donation, or L-type Ca 2ϩ channel blockade has no effect on the steady-state increase in F dev to perfusion step (5.7 Ϯ 3.2, 9.1 Ϯ 4.1, and 6.9 Ϯ 1.7 mN/mm 2 , respectively, Table 1 ). In the steady state, the perfusion step Fig. 1 . Original recordings of force, coronary flow, and muscle diameter during a perfusion pulse [brief increase in perfusion from 10 to 80 cmH2O, between two isometric contractions (A)] and during a perfusion step [(sustained increase in perfusion from 10 to 80 cmH2O) (B)] in perfused papillary muscle from the rat. After a perfusion pulse, the developed force (Fdev) was transiently increased for ϳ50 s, whereas muscle diameter returned to basal values within 10 s. After a perfusion step the Fdev increases gradually, starts to decline after 40 s and reaches an increased steady state after 125 s. The muscle diameter increases instantly due to vascular filling, followed by a gradual increase due to interstitial filling (muscle length at 100% maximal force: 4.1 mm, crosssectional area: 0.35 mm 2 ). Fig. 2 . Changes in Fdev due to a perfusion pulse (A) or a perfusion step (B) before (F) and after (E) addition of the following pharmacological agents: 1)
synthase (NOS) inhibition (middle, n ϭ 10); and 3) 10 mol/l sodium nitroprusside (SNP) NO donation (bottom, n ϭ 6). In all three groups, a perfusion pulse results in a transient increase of Fdev and a perfusion step in a sustained increase of Fdev; however, Gd results in a significant but small increase in F pas (⌬F SSpas , Table 1 ), which is not affected by the addition of any of the pharmacological agents (Table 1) .
Repetitive perfusion pulses. The absolute increase in F dev of 10 consecutive perfusion pulses (the repetitive perfusion pulses, n ϭ 4) on F dev is shown in Fig. 3 . Repetitive perfusion pulses result in an immediate increase in F dev of 1.5 Ϯ 0.6 mN/mm 2 , which is not significantly different from the perfusion pulse or stepinduced immediate increase in F dev . After 40 s, when two pulses still are to be applied, the increase in F dev already starts to decrease. The maximal increase in F dev of the repetitive perfusion pulses is 7. transient. Table 1 shows that the averaged optimal muscle length (L max ) and the averaged cross-sectional area of the muscles are statistically not different between the experimental groups. In basal conditions, i.e., low perfusion (10 cmH 2 O) and at 95% L max, F pas (see Table 1 ) is not different between the groups and not affected by the addition of one of the pharmacological agents. The absolute values of F dev at basal conditions (see Table 1 ) are not affected by addition of Gd 3ϩ , L-NNA, SNP, or streptomycin, whereas addition of verapamil and Gd 3ϩ under HEPES conditions result in a decrease of basal F dev of 56.0 Ϯ 4.5% and 43.1 Ϯ 8.5%, respectively ( Table 1) .
The last column in Table 1 shows that the absolute values of coronary flow at high perfusion (80 cmH 2 O) are not affected by the addition of Gd 3ϩ or SNP, whereas L-NNA significantly reduced coronary flow. In the streptomycin, verapamil, or HEPES experiments, the relative flow values were not different between the control group and after addition of a pharmacological agent (data not shown); unfortunately, technical problems did not allow us to obtain accurate absolute flow measurements in these experiments. Figure 4 shows, from a separate series of experiments, that the addition of Gd 3ϩ in basal conditions (low perfusion) does not affect the passive or peak [Ca 2ϩ ] i transient.
DISCUSSION
Our study shows that a short-lived, a repetitive, and a sustained increase in coronary perfusion pressure result in an increase in F dev . Similar immediate increases in F dev are seen with all three perfusion protocols; the peak value and the time constant of the increase in F dev , in response to the repetitive and and streptomycin, whereas nitric oxide (NO) inhibition (L-NNA), NO donation (SNP), and L-type Ca 2ϩ -channel blockade (verapamil) did not affect the Gregg effect. * P Ͻ 0.05 vs. low perfusion pressure; † P Ͻ 0.05 vs. control. Fig. 3 . The change in Fdev due to repetitive perfusion pulses, consisting of 10 consecutive perfusion pulses, before (F) and after (E) SAC blockade (10 mol/l Gd 3ϩ ). Repetitive perfusion pulses result in an increase in Fdev, which, after 40 s, when two pulses still are to be applied, starts to decrease. The repetitive perfusion pulses-induced response is inhibited by SAC blockade. Each point represents the mean Ϯ SE (n ϭ 4). *P Ͻ 0. ), but not affected by NOS inhibition (L-NNA) or NO donation (SNP). Another SAC blocker, streptomycin, dose dependently inhibited the perfusion step-induced increase in F dev , whereas blockade of L-type Ca 2ϩ channels with verapamil did not affect the perfusioninduced increase in F dev . We conclude that brief, repetitive, or sustained increases in coronary perfusion augment cardiac contractility through activation of stretch-activated ion channels, whereas endothelial NO release and L-type Ca 2ϩ channels are not involved. Perfusion-induced changes. In our isolated perfused papillary muscles, where autoregulation is restricted due to adenosine addition, an increase in coronary perfusion pressure results in an increase in F dev , the Gregg effect, and is in line with earlier findings (13, 16, 36) . From the literature it is known that in perfused papillary muscles an increase in oxygen delivery is not responsible (17, 36) . It has also been suggested (2) that the perfusion-induced response is related to a change in sarcomere length ("garden hose" effect). Our perfusion pulse experiments show that at the second contraction after a perfusion pulse the increase in F pas and muscle diameter (Fig. 1 ) have returned to basal values, whereas F dev remains increased. Moreover, SAC blockade by either Gd 3ϩ or streptomycin inhibits the perfusion-induced increase in developed tension with no effect on the small perfusion-induced increase in passive tension ( Table 1 ), indicating that the perfusioninduced changes are not related to changes in myofilament overlap. Thus our experimental results are in line with literature (25) showing that the perfusioninduced response is not related to a change in sarcomere length.
In our experiments, NOS inhibition by L-NNA or NO donation by SNP did not affect the responses to a perfusion change, indicating that the increase in cardiac contractility to a perfusion change is not related to shear stress-induced NO release by endothelial cells. Coronary flow at high coronary perfusion was reduced by L-NNA, indicating that NOS inhibition by L-NNA was active (Table 1) .
The verapamil experiments show that L-type Ca 2ϩ channel inhibition does not affect the perfusion-induced increase in F dev (Table 1) , which indicates that L-type Ca 2ϩ channel activation does not underlie the Gregg effect.
The SAC blocker Gd 3ϩ completely blunts all three perfusion-induced increases in F dev . Streptomycin, another SAC blocker (19) , dose dependently inhibits the increase in F dev to a perfusion step. The Gregg effect, therefore, involves activation of SACs. Cardiac myocytes exhibit activation of SACs, which is inhibited by Gd 3ϩ (24, 37, 40) . Activation of SACs in heart cells can lead to changes in fluxes of Ca 2ϩ , Na ϩ , or K ϩ cations (7, 8, 35, 37, 39, 40) , which may affect the myocardial contractile state.
The involvement of SACs in the perfusion-induced increase in cardiac contractility is confirmed by comparable properties of SACs activation and perfusioninduced responses. An increase in perfusion results in an immediate (5 s) increase in F dev of similar magnitude for all three perfusion protocols. Similarly, the stretch-induced inward cation current via SACs appeared within 10 ms in rat ventricular myocytes (5, 40) , indicating that SACs activation is fast enough to account for the perfusion-induced response. The perfusion-induced increase in F dev immediately starts to decrease when the perfusion pressure is lowered (data not shown), which is in accordance with the results that the SACs cation currents disappear when the stimulus is released (4, 40) .
The mechanisms by which the mechanosensitive activation of SACs is linked to the perfusion-induced increase in cardiac contractility are still speculative; they do not only involve changes in calcium availability and calcium sensitivity, but also cytoskeletal changes. Glogauer et al. (21) showed, in human gingival fibroblasts, that a single 1-s stretching force application resulted in a SACs-mediated increase of [Ca 2ϩ ] i , which lasted 150 s. A similar mechanism may underlie the transient increase in F dev by the P-pulse (Figs. 1 and 2 ) because F dev remained increased for several contractions, whereas muscle diameter quickly returned to basal values. In chicken cardiomyocytes, a mechanical stimulus by pressing the membrane elicited an inward cation current, which slowly inactivated during the plateau phase, probably due to changes in the cytoskeleton (4), a process that is also seen at sustained perfusion pressures resulting in adaptation of SACs (34) . In another study, Glogauer et al. (20) showed that repetitive force application progressively inhibited the amplitude of the force-induced [Ca 2ϩ ] i increase, which is compatible with our observation that maximum value and time constant of the increase in F dev are not different between repetitive perfusion pulses and perfusion step. From the present results we propose a likely mechanism for the Gregg effect. Increased coronary perfusion via hoop (circumferential) stress mechanically deforms (by stretching or changing shape) the membrane of cardiomyocytes. A basis for the deformation of the membrane of the cardiomyocytes by increased perfusion pressures is provided by the findings of Heslinga et al. (23) , who showed in isolated perfused papillary muscles that an increase in coronary perfusion resulted in an increase in intramyocardial pressure. The membrane deformation changes ion fluxes through SACs, resulting in increased cardiac contractility. This hypothesis is supported by the findings that the Gregg response was related to capillary perfusion (13, 15) and changes in coronary vascular volume (3), but was not related to arterial endothelium or its released inotropic substances (12, 14, 32, 33) . The identity of the coronary perfusion-induced increased cation influx is not yet clear and needs further experiments.
Gadolinium. The use of Gd 3ϩ to block stretch-activated ion channels has been questioned in literature (28, 9 (19) , show a dose-dependent inhibition of the perfusion-induced increase in F dev (Table 1), confirming that SACs underlie the Gregg effect. These results also make it unlikely that the inhibition of the Gregg effect by Gd 3ϩ is a nonspecific side effect, because two different types of SAC blockers, Gd 3ϩ and streptomycin, would then have a similar nonspecific side effect. The findings of Nicolosi et al. (31) support the fact that Gd 3ϩ blocks SACs in bicarbonate conditions: Gd 3ϩ was able to eliminate the adverse effects of overstretching in isolated guinea pig papillary muscles using a solution with bicarbonate without affecting basal force development.
The experiments with the L-type Ca 2ϩ channel blocker verapamil (Table 1) , which resulted in a decrease of basal force of 56.0 Ϯ 4.5%, did not affect the perfusion-induced increase in F dev . These results, together with the absence of a decrease of basal force development (Table 1 ) and no change in basal [Ca 2ϩ ] i transient (Fig. 4) Lacampagne et al. (28) . This suggests that the inhibition of L-type Ca 2ϩ channels by Gd 3ϩ depend on its conformation: the "free" form inhibits L-type Ca 2ϩ channels whereas the "bicarbonate-bound" form does not.
Therefore, our results and other studies (6, 31) show clearly that Gd 3ϩ , in the presence of bicarbonate, does block SACs and that the perfusion-induced increase in F dev (Gregg effect ) is related to activation of SACs and not to L-type Ca 2ϩ channel blockade or a nonspecific side effect of Gd 3ϩ . Implications. Dankelman et al. (10, 11) clearly showed that the Gregg effect is present under normal physiological conditions; however, it is not observable due to the speed of autoregulation. The Gregg effect will be uncovered during ineffective autoregulation (16) , which can occur in pathological situations, such as the onset of hibernation or distal from a stenosis, where autoregulation is restricted. When coronary perfusion increases, stretch of the membranes of cardiomyocytes will activate SACs, and cardiac contractility and oxygen consumption will increase. When coronary perfusion decreases, reduced deformation of the membranes of cardiomyocytes will inactivate SACs, and cardiac contraction and oxygen consumption will be reduced. Therefore, the Gregg effect may constitute an immediate protective mechanism in preventing a mismatch between cardiac contractility and oxygen delivery. In low coronary perfusion conditions, when autoregulation is ineffective, the Gregg effect may constitute an immediate mechanism that increases the pump function of the heart after increased coronary perfusion. A similar statement was made by Merkus et al. (29) , who found a shorter diastolic time fraction (earlier onset of relaxation) at lower perfusion pressures in anesthetized open-chest dogs. Changes in interstitial volume and changes in buffer capacity for ions were put forward as mechanisms, whereas the involvement of oxygen shortage or a NO pathway was excluded. These findings are similar for the Gregg effect, as mentioned in this study. Unfortunately, the role of SACs was not investigated by Merkus et al. (29) , which would have provided more information on a common mechanism for the effect of perfusion changes on cardiac contraction. We conclude that brief, repetitive, or sustained increases in coronary perfusion augment cardiac contractility through activation of stretch-activated ion channels, whereas endothelial NO release and L-type Ca 2ϩ channels are not involved.
